# Polypill Strategy for Heart Failure With Reduced Ejection Fraction

> **NCT04633005** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 212 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Polypill
- **DRUG:** Control Rx

## Key facts

- **NCT ID:** NCT04633005
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-31
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04633005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04633005, "Polypill Strategy for Heart Failure With Reduced Ejection Fraction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04633005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*